by Lengea Law | Dec 13, 2023 | News
In the constantly changing landscape of the law surrounding medical spa and aesthetics businesses, it’s extremely important to stay current on state regulations and advisory opinions from state regulatory boards. A new Advisory Opinion from the Arizona Board of...
by Lengea Law | Nov 7, 2023 | News
Changes to USP 797 regarding compounding took effect on November 1, 2023. Anyone who performs IV hydration needs to understand these changes and comply with them. USP 797 requires everyone who performs IV hydration to have written protocols and documented training. If...
by Lengea Law | Oct 12, 2023 | News
In November 2022, the US Pharmacopeia (USP) released updates to their General Chapters on Compounding for sterile and non-sterile preparations that will go into effect on November 1, 2023. The question coming out of these updates is: how will they alter how I run my...
by Lengea Law | Sep 21, 2023 | News
Daxxify is a new FDA-approved neuromodulator by Revance Therapeutics (“Revance”) designed to soften the look of fine lines and wrinkles. Daxxify differs from Botox and other botulinum toxin injectables, like Xeomin, Juveau, and Dysport, in that it is designed to work...
by Lengea Law | Aug 2, 2023 | News
New reporting requirements for LLCs will begin to take effect in 2024 under the Corporate Transparency Act, a federal law aimed at preventing money laundering that was passed in 2021. The penalties for failure to comply with these requirements potentially include a...
by Lengea Law | Jul 26, 2023 | News
The Florida Board of Nursing released a new declaratory statement regarding aesthetic injections, which has garnered attention from registered nurses (RNs) nationwide. Florida has had ambiguous rules for several years regarding whether RNs may inject Botox and...
